Molecular Partners AG (MOLN)
4.204
-0.32
(-6.99%)
USD |
NASDAQ |
Dec 08, 16:00
4.15
-0.05
(-1.28%)
After-Hours: 20:00
Molecular Partners Shareholders Equity (Quarterly): 120.06M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 4.129B |
| AC Immune SA | 78.48M |
| CRISPR Therapeutics AG | 1.916B |
| Addex Therapeutics Ltd. | 7.480M |
| NewCelX Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 140.95M |
| Total Liabilities (Quarterly) | 20.89M |
| Debt to Equity Ratio | 0.016 |
| Current Ratio | 9.280 |
| Net Debt Paydown Yield | 0.21% |